{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:49:31Z","timestamp":1793335771049,"version":"4.5.0"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104357"],"award-info":[{"award-number":["82104357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The blood\u2013brain barrier (BBB) represents a formidable challenge in the treatment of neurological disorders, as it restricts the passage of most therapeutic agents into the central nervous system (CNS). Research in brain-targeted delivery strategies and explore in natural products for BBB modulation have opened new avenues for effective CNS drug delivery. This review highlights the latest developments in molecular-based delivery systems, cell-based approaches, physical techniques, toxicity concerns, clinical trials and artificial intelligence (AI) -driven modeling for brain-targeted drug delivery. Additionally, it examines the role of natural products, particularly aromatic resuscitation medicines, in enhancing BBB permeability through modulating tight junction proteins and inhibiting efflux transporters. It is emphasized that the integration of natural products with modern drug delivery systems offers promising opportunities for the development of novel brain-targeted therapies. However, challenges related to the complexity and variety of natural product compositions must be addressed to fully realize their potential. This review underscores the importance of continued research into the molecular mechanisms underlying BBB modulation and natural product-mediated nano-delivery strategies for CNS disorders.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-025-03415-w","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T13:19:50Z","timestamp":1748265590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood\u2013brain barrier permeability"],"prefix":"10.1186","volume":"23","author":[{"given":"Suyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie-an","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"3415_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","volume":"16","author":"K Aldape","year":"2019","unstructured":"Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, et al. Challenges to curing primary brain tumours. Nat Rev Clin Oncol. 2019;16:509\u201320.","journal-title":"Nat Rev Clin Oncol"},{"key":"3415_CR2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-150896","author":"P Dhakal","year":"2021","unstructured":"Dhakal P, Lyden ER, Joshi U, Pyakuryal A, Gundabolu K. Poor outcomes of older adults with acute promyelocytic leukemia (APL) regardless of insurance types. Blood. 2021. https:\/\/doi.org\/10.1182\/blood-2021-150896.","journal-title":"Blood"},{"key":"3415_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-212922","volume":"12","author":"BR De Miranda","year":"2022","unstructured":"De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. Preventing Parkinson\u2019s disease: an environmental agenda. J Parkinsons Dis. 2022;12:45\u201368.","journal-title":"J Parkinsons Dis"},{"key":"3415_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","volume":"1","author":"Y Persidsky","year":"2006","unstructured":"Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol. 2006;1:223\u201336.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3415_CR5","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.4103\/1673-5374.280308","volume":"15","author":"D Fisher","year":"2020","unstructured":"Fisher D, Mentor S. Are claudin-5 tight-junction proteins in the blood-brain barrier porous? Neural Regen Res. 2020;15:1838\u20139.","journal-title":"Neural Regen Res"},{"key":"3415_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/bs.vh.2024.05.001","volume":"126","author":"S Ohtsuki","year":"2024","unstructured":"Ohtsuki S. Insulin receptor at the blood-brain barrier: transport and signaling. Vitam Horm. 2024;126:113\u201324.","journal-title":"Vitam Horm"},{"key":"3415_CR7","doi-asserted-by":"publisher","first-page":"8702","DOI":"10.1007\/s12035-024-04015-9","volume":"61","author":"A Mhaske","year":"2024","unstructured":"Mhaske A, Shukla S, Ahirwar K, Singh KK, Shukla R. Receptor-assisted nanotherapeutics for overcoming the blood-brain barrier. Mol Neurobiol. 2024;61:8702\u201338.","journal-title":"Mol Neurobiol"},{"key":"3415_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.neuron.2022.02.017","volume":"110","author":"S Ayloo","year":"2022","unstructured":"Ayloo S, Lazo CG, Sun S, Zhang W, Cui B, Gu C. Pericyte-to-endothelial cell signaling via vitronectin-integrin regulates blood-CNS barrier. Neuron. 2022;110:1641-1655.e6.","journal-title":"Neuron"},{"key":"3415_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1124\/pharmrev.120.000025","volume":"75","author":"JA Schulz","year":"2023","unstructured":"Schulz JA, Hartz AMS, Bauer B. ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery. Pharmacol Rev. 2023;75:815\u201353.","journal-title":"Pharmacol Rev"},{"key":"3415_CR10","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1166\/jnn.2014.9119","volume":"14","author":"A Dom\u00ednguez","year":"2014","unstructured":"Dom\u00ednguez A, Su\u00e1rez-Merino B, Go\u00f1i-de-Cerio F. Nanoparticles and blood-brain barrier: the key to central nervous system diseases. J Nanosci Nanotechnol. 2014;14:766\u201379.","journal-title":"J Nanosci Nanotechnol"},{"key":"3415_CR11","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ac85f3","author":"T Liu","year":"2022","unstructured":"Liu T, Xie Q, Dong Z, Peng Q. Nanoparticles-based delivery system and its potentials in treating central nervous system disorders. Nanotechnology. 2022. https:\/\/doi.org\/10.1088\/1361-6528\/ac85f3.","journal-title":"Nanotechnology"},{"key":"3415_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","volume":"270","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Peng Z, Seven ES, Leblanc RM. Crossing the blood-brain barrier with nanoparticles. J Control Release. 2018;270:290\u2013303.","journal-title":"J Control Release"},{"key":"3415_CR13","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.2147\/IJN.S454553","volume":"19","author":"A Kakinen","year":"2024","unstructured":"Kakinen A, Jiang Y, Davis TP, Teesalu T, Saarma M. Brain targeting nanomedicines: pitfalls and promise. Int J Nanomedicine. 2024;19:4857\u201375.","journal-title":"Int J Nanomedicine"},{"key":"3415_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-230098","volume":"96","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shen Y. Applications of nanoparticles in Alzheimer\u2019s disease. J Alzheimers Dis. 2023;96:459\u201371.","journal-title":"J Alzheimers Dis"},{"key":"3415_CR15","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1038\/s41467-023-43995-5","volume":"14","author":"S Lee","year":"2023","unstructured":"Lee S, Kim E, Moon CE, Park C, Lim JW, Baek M, Shin MK, Ki J, Cho H, Ji YW, et al. Amplified fluorogenic immunoassay for early diagnosis and monitoring of Alzheimer\u2019s disease from tear fluid. Nat Commun. 2023;14:8153.","journal-title":"Nat Commun"},{"key":"3415_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.342623","volume":"1306","author":"YO Jang","year":"2024","unstructured":"Jang YO, Roh Y, Shin W, Jo S, Koo B, Liu H, Kim MG, Lee HJ, Qiao Z, Lee EY, et al. Transferrin-conjugated magnetic nanoparticles for the isolation of brain-derived blood exosomal MicroRNAs: a novel approach for Parkinson\u2019s disease diagnosis. Anal Chim Acta. 2024;1306: 342623.","journal-title":"Anal Chim Acta"},{"key":"3415_CR17","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1002\/ptr.7955","volume":"37","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Jiang Q, Sa K, Liang J, Sun D, Li H, Chen L. Research progress of plant-derived natural alkaloids in central nervous system diseases. Phytother Res. 2023;37:4885\u2013907.","journal-title":"Phytother Res"},{"key":"3415_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107395","volume":"208","author":"XX Wang","year":"2024","unstructured":"Wang XX, Ji X, Lin J, Wong IN, Lo HH, Wang J, Qu L, Wong VKW, Chung SK, Law BYK. GPCR-mediated natural products and compounds: potential therapeutic targets for the treatment of neurological diseases. Pharmacol Res. 2024;208: 107395.","journal-title":"Pharmacol Res"},{"key":"3415_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbi.2023.10.018","volume":"115","author":"J Wen","year":"2024","unstructured":"Wen J, Satyanarayanan SK, Li A, Yan L, Zhao Z, Yuan Q, Su KP, Su H. Unraveling the impact of Omega-3 polyunsaturated fatty acids on blood-brain barrier (BBB) integrity and glymphatic function. Brain Behav Immun. 2024;115:335\u201355.","journal-title":"Brain Behav Immun"},{"key":"3415_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/ijms15010895","volume":"15","author":"D Sawmiller","year":"2014","unstructured":"Sawmiller D, Li S, Shahaduzzaman M, Smith AJ, Obregon D, Giunta B, Borlongan CV, Sanberg PR, Tan J. Luteolin reduces Alzheimer\u2019s disease pathologies induced by traumatic brain injury. Int J Mol Sci. 2014;15:895\u2013904.","journal-title":"Int J Mol Sci"},{"key":"3415_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.apsb.2019.01.006","volume":"9","author":"C Gao","year":"2019","unstructured":"Gao C, Liang J, Zhu Y, Ling C, Cheng Z, Li R, Qin J, Lu W, Wang J. Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy. Acta Pharm Sin B. 2019;9:843\u201357.","journal-title":"Acta Pharm Sin B"},{"key":"3415_CR22","first-page":"3312","volume":"54","author":"L Fang","year":"2023","unstructured":"Fang L, Tao WK, Cheng HY, Li DW, Wang YF, Xu AQ, Zhang CY. Research progress on mechanism of uplink of traditional Chinese medicine and its brain targeting preparations. Chinese Tradit Herbal Drugs. 2023;54:3312\u201321.","journal-title":"Chinese Tradit Herbal Drugs"},{"key":"3415_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123284","volume":"643","author":"S Yu","year":"2023","unstructured":"Yu S, Wang X, Lv L, Liu T, Guan Q. Borneol-modified PEGylated graphene oxide as a nanocarrier for brain-targeted delivery of ginsenoside Rg1 against depression. Int J Pharm. 2023;643: 123284.","journal-title":"Int J Pharm"},{"key":"3415_CR24","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1021\/acschemneuro.4c00109","volume":"15","author":"WY Liu","year":"2024","unstructured":"Liu WY, Yu Y, Zang J, Liu Y, Li FR, Zhang L, Guo RB, Kong L, Ma LY, Li XT. Menthol-modified quercetin liposomes with brain-targeting function for the treatment of senescent Alzheimer\u2019s disease. ACS Chem Neurosci. 2024;15:2283\u201395.","journal-title":"ACS Chem Neurosci"},{"key":"3415_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:217.","journal-title":"Signal Transduct Target Ther"},{"key":"3415_CR26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.bbamem.2007.08.017","volume":"1778","author":"H Chiba","year":"2008","unstructured":"Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2008;1778:588\u2013600.","journal-title":"Biochim Biophys Acta"},{"key":"3415_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1083\/jcb.103.3.755","volume":"103","author":"BR Stevenson","year":"1986","unstructured":"Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. 1986;103:755\u201366.","journal-title":"J Cell Biol"},{"key":"3415_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1023\/A:1006995910836","volume":"20","author":"U Kniesel","year":"2000","unstructured":"Kniesel U, Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol. 2000;20:57\u201376.","journal-title":"Cell Mol Neurobiol"},{"key":"3415_CR29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1152\/physrev.00035.2003","volume":"84","author":"G Bazzoni","year":"2004","unstructured":"Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84:869\u2013901.","journal-title":"Physiol Rev"},{"key":"3415_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cobme.2017.11.002","volume":"5","author":"BD Gastfriend","year":"2018","unstructured":"Gastfriend BD, Palecek SP, Shusta EV. Modeling the blood-brain barrier: beyond the endothelial cells. Curr Opin Biomed Eng. 2018;5:6\u201312.","journal-title":"Curr Opin Biomed Eng"},{"key":"3415_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/svn-2018-000198","volume":"4","author":"L Xu","year":"2019","unstructured":"Xu L, Nirwane A, Yao Y. Basement membrane and blood-brain barrier. Stroke Vasc Neurol. 2019;4:78\u201382.","journal-title":"Stroke Vasc Neurol"},{"key":"3415_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","volume":"46","author":"B D\u00edaz-Castro","year":"2023","unstructured":"D\u00edaz-Castro B, Robel S, Mishra A. Astrocyte endfeet in brain function and pathology: open questions. Annu Rev Neurosci. 2023;46:101\u201321.","journal-title":"Annu Rev Neurosci"},{"key":"3415_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik A, Genov\u00e9 G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21:193\u2013215.","journal-title":"Dev Cell"},{"key":"3415_CR34","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.4103\/1673-5374.373677","volume":"18","author":"SK Halder","year":"2023","unstructured":"Halder SK, Sapkota A, Milner R. The importance of laminin at the blood-brain barrier. Neural Regen Res. 2023;18:2557\u201363.","journal-title":"Neural Regen Res"},{"key":"3415_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914954","author":"M Choi","year":"2023","unstructured":"Choi M, Ryu J, Vu HD, Kim D, Youn YJ, Park MH, Huynh PT, Hwang GB, Youn SW, Jeong YH. Transferrin-conjugated Melittin-loaded l-arginine-coated iron oxide nanoparticles for mitigating beta-amyloid pathology of the 5XFAD mouse brain. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241914954.","journal-title":"Int J Mol Sci"},{"key":"3415_CR36","doi-asserted-by":"publisher","first-page":"14191","DOI":"10.1021\/acsanm.3c02122","volume":"6","author":"MJ Ramalho","year":"2023","unstructured":"Ramalho MJ, Torres ID, Loureiro JA, Lima J, Pereira MC. Transferrin-conjugated PLGA nanoparticles for co-delivery of temozolomide and bortezomib to glioblastoma cells. ACS Appl Nano Mater. 2023;6:14191\u2013203.","journal-title":"ACS Appl Nano Mater"},{"key":"3415_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203742","volume":"10","author":"SY Wu","year":"2023","unstructured":"Wu SY, Ye YX, Zhang Q, Kang QJ, Xu ZM, Ren SZ, Lin F, Duan YT, Xu HJ, Hu ZY, et al. Multifunctional protein hybrid nanoplatform for synergetic photodynamic-chemotherapy of malignant carcinoma by homologous targeting combined with oxygen transport. Adv Sci (Weinh). 2023;10: e2203742.","journal-title":"Adv Sci (Weinh)"},{"key":"3415_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/nat.2019.0807","volume":"30","author":"J Macdonald","year":"2020","unstructured":"Macdonald J, Denoyer D, Henri J, Jamieson A, Burvenich IJG, Pouliot N, Shigdar S. Bifunctional aptamer-doxorubicin conjugate crosses the blood-brain barrier and selectively delivers its payload to EpCAM-positive tumor cells. Nucleic Acid Ther. 2020;30:117\u201328.","journal-title":"Nucleic Acid Ther"},{"key":"3415_CR39","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.2147\/IJN.S255902","volume":"15","author":"MS Ashrafzadeh","year":"2020","unstructured":"Ashrafzadeh MS, Akbarzadeh A, Heydarinasab A, Ardjmand M. In vivo glioblastoma therapy using targeted liposomal cisplatin. Int J Nanomedicine. 2020;15:7035\u201349.","journal-title":"Int J Nanomedicine"},{"key":"3415_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061122","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Du W, Zhou L, Wu J, Zhang X, Wei X, Wang S, Huang Y, Li Y. Transferrin-enabled blood-brain barrier crossing manganese-based nanozyme for rebalancing the reactive oxygen species level in ischemic stroke. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14061122.","journal-title":"Pharmaceutics"},{"key":"3415_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13030402","author":"V Perumal","year":"2023","unstructured":"Perumal V, Ravula AR, Agas A, Gosain A, Aravind A, Sivakumar PM, Sambath K, Vijayaraghavalu S, Chandra N. Enhanced targeted delivery of minocycline via transferrin conjugated albumin nanoparticle improves neuroprotection in a blast traumatic brain injury model. Brain Sci. 2023. https:\/\/doi.org\/10.3390\/brainsci13030402.","journal-title":"Brain Sci"},{"key":"3415_CR42","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.2147\/IJN.S239608","volume":"15","author":"L Kong","year":"2020","unstructured":"Kong L, Li XT, Ni YN, Xiao HH, Yao YJ, Wang YY, Ju RJ, Li HY, Liu JJ, Fu M, et al. Transferrin-modified osthole PEGylated liposomes travel the blood-brain barrier and mitigate Alzheimer\u2019s disease-related pathology in APP\/PS-1 mice. Int J Nanomed. 2020;15:2841\u201358.","journal-title":"Int J Nanomed"},{"key":"3415_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113270","volume":"225","author":"S Andrade","year":"2023","unstructured":"Andrade S, Pereira MC, Loureiro JA. Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer\u2019s disease therapy. Colloids Surf B Biointerfaces. 2023;225: 113270.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3415_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111404","author":"C Wu","year":"2024","unstructured":"Wu C, Zhang J, Yang S, Peng C, Lv M, Liang J, Li X, Xie L, Wei Y, Chen H, et al. Preparation and pharmacokinetics of brain-targeted nanoliposome loaded with Rutin. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252111404.","journal-title":"Int J Mol Sci"},{"key":"3415_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121395","volume":"613","author":"S Mojarad-Jabali","year":"2022","unstructured":"Mojarad-Jabali S, Farshbaf M, Hemmati S, Sarfraz M, Motasadizadeh H, Shahbazi Mojarrad J, Atyabi F, Zakeri-Milani P, Valizadeh H. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy. Int J Pharm. 2022;613: 121395.","journal-title":"Int J Pharm"},{"key":"3415_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jconrel.2023.11.033","volume":"365","author":"R Wang","year":"2024","unstructured":"Wang R, Wang X, Zhao H, Li N, Li J, Zhang H, Di L. Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma. J Control Release. 2024;365:331\u201347.","journal-title":"J Control Release"},{"key":"3415_CR47","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1080\/10717544.2018.1494223","volume":"25","author":"M Liang","year":"2018","unstructured":"Liang M, Gao C, Wang Y, Gong W, Fu S, Cui L, Zhou Z, Chu X, Zhang Y, Liu Q, et al. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles. Drug Deliv. 2018;25:1652\u201363.","journal-title":"Drug Deliv"},{"key":"3415_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/1061186X.2021.1927055","volume":"30","author":"Q Ouyang","year":"2022","unstructured":"Ouyang Q, Meng Y, Zhou W, Tong J, Cheng Z, Zhu Q. New advances in brain-targeting nano-drug delivery systems for Alzheimer\u2019s disease. J Drug Target. 2022;30:61\u201381.","journal-title":"J Drug Target"},{"key":"3415_CR49","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.drudis.2021.02.008","volume":"26","author":"S Pawar","year":"2021","unstructured":"Pawar S, Koneru T, McCord E, Tatiparti K, Sau S, Iyer AK. LDL receptors and their role in targeted therapy for glioma: a review. Drug Discov Today. 2021;26:1212\u201325.","journal-title":"Drug Discov Today"},{"key":"3415_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124552","volume":"663","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Li J, Wang Y, Tang C, Zhou Y, Li J, Lu X, Wang Y, Ma T, Xu H, et al. Angiopep-2 conjugated biomimetic nano-delivery system loaded with resveratrol for the treatment of methamphetamine addiction. Int J Pharm. 2024;663: 124552.","journal-title":"Int J Pharm"},{"key":"3415_CR51","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1021\/acsnano.2c00320","volume":"16","author":"W He","year":"2022","unstructured":"He W, Li X, Morsch M, Ismail M, Liu Y, Rehman FU, Zhang D, Wang Y, Zheng M, Chung R, et al. Brain-targeted codelivery of Bcl-2\/Bcl-xl and Mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy. ACS Nano. 2022;16:6293\u2013308.","journal-title":"ACS Nano"},{"key":"3415_CR52","doi-asserted-by":"publisher","first-page":"104794","DOI":"10.1016\/j.jddst.2023.104794","volume":"87","author":"Y Yu","year":"2023","unstructured":"Yu Y, He S-Y, Kong L, Shi N-N, Liu Y, Zang J, Guo R-B, Zhang L, Li X-Y, et al. Brain-targeted multifunctional micelles delivering oridonin and phillyrin for synergistic therapy of Alzheimer\u2019s disease. J Drug Deliv Sci Technol. 2023;87:104794.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3415_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409176","author":"R Wang","year":"2024","unstructured":"Wang R, Nie W, Yan X, Luo K, Zhang Q, Wang T, Lu E, Chen Y, Luo Y, Zhang Z, et al. Biomimetic nanomotors for deep ischemia penetration and ferroptosis inhibition in neuroprotective therapy of ischemic stroke. Adv Mater. 2024. https:\/\/doi.org\/10.1002\/adma.202409176.","journal-title":"Adv Mater"},{"key":"3415_CR54","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.ijbiomac.2020.11.107","volume":"167","author":"MM Agwa","year":"2021","unstructured":"Agwa MM, Sabra S. Lactoferrin coated or conjugated nanomaterials as an active targeting approach in nanomedicine. Int J Biol Macromol. 2021;167:1527\u201343.","journal-title":"Int J Biol Macromol"},{"key":"3415_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijbiomac.2020.06.058","volume":"162","author":"MM Agwa","year":"2020","unstructured":"Agwa MM, Abdelmonsif DA, Khattab SN, Sabra S. Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer\u2019s disease. Int J Biol Macromol. 2020;162:246\u201361.","journal-title":"Int J Biol Macromol"},{"key":"3415_CR56","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jconrel.2023.02.002","volume":"355","author":"HH Hwang","year":"2023","unstructured":"Hwang HH, Kim HS, Lee DY. Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor. J Control Release. 2023;355:730\u201344.","journal-title":"J Control Release"},{"key":"3415_CR57","doi-asserted-by":"publisher","first-page":"16909","DOI":"10.1039\/D1NR03553C","volume":"13","author":"TI Janjua","year":"2021","unstructured":"Janjua TI, Ahmed-Cox A, Meka AK, Mansfeld FM, Forgham H, Ignacio RMC, Cao Y, McCarroll JA, Mazzieri R, Kavallaris M, et al. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma. Nanoscale. 2021;13:16909\u201322.","journal-title":"Nanoscale"},{"key":"3415_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jconrel.2023.03.040","volume":"357","author":"TI Janjua","year":"2023","unstructured":"Janjua TI, Cao Y, Ahmed-Cox A, Raza A, Moniruzzaman M, Akhter DT, Fletcher NL, Kavallaris M, Thurecht KJ, Popat A. Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma. J Control Release. 2023;357:161\u201374.","journal-title":"J Control Release"},{"key":"3415_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2022.04.003","volume":"346","author":"N Katila","year":"2022","unstructured":"Katila N, Duwa R, Bhurtel S, Khanal S, Maharjan S, Jeong JH, Lee S, Choi DY, Yook S. Enhancement of blood-brain barrier penetration and the neuroprotective effect of resveratrol. J Control Release. 2022;346:1\u201319.","journal-title":"J Control Release"},{"key":"3415_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120339","volume":"260","author":"S Xiong","year":"2020","unstructured":"Xiong S, Li Z, Liu Y, Wang Q, Luo J, Chen X, Xie Z, Zhang Y, Zhang H, Chen T. Brain-targeted delivery shuttled by black phosphorus nanostructure to treat Parkinson\u2019s disease. Biomaterials. 2020;260: 120339.","journal-title":"Biomaterials"},{"key":"3415_CR61","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1039\/D0BM01765E","volume":"9","author":"S Xiong","year":"2021","unstructured":"Xiong S, Luo J, Wang Q, Li Z, Li J, Liu Q, Gao L, Fang S, Li Y, Pan H, et al. Targeted graphene oxide for drug delivery as a therapeutic nanoplatform against Parkinson\u2019s disease. Biomater Sci. 2021;9:1705\u201315.","journal-title":"Biomater Sci"},{"key":"3415_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10393","volume":"8","author":"N Qi","year":"2023","unstructured":"Qi N, Duan W, Gao D, Ma N, Zhang J, Feng J, Li A. \u201cGuide\u201d of muscone modification enhanced brain-targeting efficacy and anti-glioma effect of lactoferrin modified DTX liposomes. Bioeng Transl Med. 2023;8: e10393.","journal-title":"Bioeng Transl Med"},{"key":"3415_CR63","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/1061186X.2015.1132223","volume":"24","author":"YC Kuo","year":"2016","unstructured":"Kuo YC, Wang IH. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles. J Drug Target. 2016;24:645\u201354.","journal-title":"J Drug Target"},{"key":"3415_CR64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407936121","volume":"121","author":"N Kamei","year":"2024","unstructured":"Kamei N, Ikeda K, Ohmoto Y, Fujisaki S, Shirata R, Maki M, Miyata M, Miyauchi Y, Nishiyama N, Yamada M, et al. Insulin-inspired hippocampal neuron-targeting technology for protein drug delivery. Proc Natl Acad Sci U S A. 2024;121: e2407936121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3415_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071452","author":"A Yogi","year":"2022","unstructured":"Yogi A, Hussack G, van Faassen H, Haqqani AS, Delaney CE, Brunette E, Sandhu JK, Hewitt M, Sulea T, Kemmerich K, et al. Brain delivery of IGF1R5, a single-domain antibody targeting insulin-like growth factor-1 receptor. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14071452.","journal-title":"Pharmaceutics"},{"key":"3415_CR66","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1016\/j.biomaterials.2013.03.013","volume":"34","author":"YC Kuo","year":"2013","unstructured":"Kuo YC, Ko HF. Targeting delivery of saquinavir to the brain using 83\u201314 monoclonal antibody-grafted solid lipid nanoparticles. Biomaterials. 2013;34:4818\u201330.","journal-title":"Biomaterials"},{"key":"3415_CR67","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1021\/acsomega.0c05500","volume":"6","author":"E McCord","year":"2021","unstructured":"McCord E, Pawar S, Koneru T, Tatiparti K, Sau S, Iyer AK. Folate receptors\u2019 expression in gliomas may possess potential nanoparticle-based drug delivery opportunities. ACS Omega. 2021;6:4111\u20138.","journal-title":"ACS Omega"},{"key":"3415_CR68","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1080\/17435889.2024.2395234","volume":"19","author":"P Pourmasoumi","year":"2024","unstructured":"Pourmasoumi P, Abdouss M, Farhadi M, Jameie SB, Khonakdar HA. Co-delivery of temozolomide and quercetin with folic acid-conjugated exosomes in glioblastoma treatment. Nanomedicine (Lond). 2024;19:2271\u201387.","journal-title":"Nanomedicine (Lond)"},{"key":"3415_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213442","volume":"151","author":"M Uribe-Robles","year":"2023","unstructured":"Uribe-Robles M, Ortiz-Islas E, Rodriguez-Perez E, Valverde FF, Lim T, Martinez-Morales AA. Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO(2) -nanospheres for the treatment of glioblastoma. Biomater Adv. 2023;151: 213442.","journal-title":"Biomater Adv"},{"key":"3415_CR70","doi-asserted-by":"publisher","first-page":"39633","DOI":"10.1021\/acsami.9b14659","volume":"11","author":"N Kuplennik","year":"2019","unstructured":"Kuplennik N, Lang K, Steinfeld R, Sosnik A. Folate receptor \u03b1-modified nanoparticles for targeting of the central nervous system. ACS Appl Mater Interfaces. 2019;11:39633\u201347.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3415_CR71","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","volume":"74","author":"C Gotti","year":"2004","unstructured":"Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74:363\u201396.","journal-title":"Prog Neurobiol"},{"key":"3415_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","volume":"80","author":"Y Liu","year":"2016","unstructured":"Liu Y, An S, Li J, Kuang Y, He X, Guo Y, Ma H, Zhang Y, Ji B, Jiang C. Coloaded with elacridar and tariquidar to modulate the p-glycoprotein at the blood-brain barriercoloaded with elacridar and tariquidar to modulate the p-glycoprotein at the blood-brain barrier. Biomaterials. 2016;80:33\u201345.","journal-title":"Biomaterials"},{"key":"3415_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/biomimetics5010011","volume":"5","author":"JS D'Arrigo","year":"2020","unstructured":"D\u2019Arrigo JS. Biomimetic nanocarrier targeting drug(s) to upstream-receptor mechanisms in dementia: focusing on linking pathogenic cascades. Biomimetics. 2020;5:11.","journal-title":"Biomimetics"},{"key":"3415_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100812","volume":"10","author":"S Singh","year":"2021","unstructured":"Singh S, Drude N, Blank L, Desai PB, K\u00f6nigs H, R\u00fctten S, Langen KJ, M\u00f6ller M, Mottaghy FM, Morgenroth A. Protease responsive nanogels for transcytosis across the blood-brain barrier and intracellular delivery of radiopharmaceuticals to brain tumor cells. Adv Healthc Mater. 2021;10: e2100812.","journal-title":"Adv Healthc Mater"},{"key":"3415_CR75","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.3390\/molecules28135206","volume":"28","author":"M Gagnon","year":"2023","unstructured":"Gagnon M, Savard M, Tran TMH, Vincent L, Moquin A, Tremblay P, Roucou X, Dory Y, Gobeil F. Evaluation of novel B1R\/B2R agonists containing TRIOZAN\u2122 nanoparticles for targeted brain delivery of antibodies in a mouse model of Alzheimer disease. Molecules. 2023;28:5206.","journal-title":"Molecules"},{"key":"3415_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc7031","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhu F, Liu Y, Zheng M, Wang Y, Zhang D, Anraku Y, Zou Y, Li J, Wu H, et al. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy. Sci Adv. 2020. https:\/\/doi.org\/10.1126\/sciadv.abc7031.","journal-title":"Sci Adv"},{"key":"3415_CR77","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","volume":"18","author":"T Lei","year":"2024","unstructured":"Lei T, Yang Z, Jiang C, Wang X, Yang W, Yang X, Xie R, Tong F, Xia X, Huang Q, et al. Mannose-integrated nanoparticle hitchhike glucose transporter 1 recycling to overcome various barriers of oral delivery for alzheimer\u2019s disease therapy. ACS Nano. 2024;18:3234\u201350.","journal-title":"ACS Nano"},{"key":"3415_CR78","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1021\/acs.molpharmaceut.2c00594","volume":"20","author":"K Bahrami","year":"2023","unstructured":"Bahrami K, J\u00e4rvinen J, Laitinen T, Reinisalo M, Honkakoski P, Poso A, Huttunen KM, Rautio J. Structural features affecting the interactions and transportability of LAT1-targeted phenylalanine drug conjugates. Mol Pharm. 2023;20:206\u201318.","journal-title":"Mol Pharm"},{"key":"3415_CR79","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1055\/a-1290-0119","volume":"71","author":"M Dhanawat","year":"2021","unstructured":"Dhanawat M, Gupta S, Mehta DK, Das R. Design, synthesis and enhanced BBB penetration studies of l-serine-tethered nipecotic acid-prodrug. Drug Res (Stuttg). 2021;71:94\u2013103.","journal-title":"Drug Res (Stuttg)"},{"key":"3415_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123418","volume":"645","author":"Z Kaboli","year":"2023","unstructured":"Kaboli Z, Hosseini MJ, Sadighian S, Rostamizadeh K, Hamidi M, Manjili HK. Valine conjugated polymeric nanocarriers for targeted co-delivery of rivastigmine and quercetin in rat model of Alzheimer disease. Int J Pharm. 2023;645: 123418.","journal-title":"Int J Pharm"},{"key":"3415_CR81","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00044-024-03225-z","volume":"33","author":"X Guan","year":"2024","unstructured":"Guan X. Glutathione transporter as a target for brain drug delivery. Med Chem Res. 2024;33:1281\u201391.","journal-title":"Med Chem Res"},{"issue":"4","key":"3415_CR82","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1021\/acsbiomaterials.8b01420","volume":"5","author":"H Nosrati","year":"2019","unstructured":"Nosrati H, Tarantash M, Bochani S, Charmi J, Bagheri Z, Fridoni M, Abdollahifar MA, Davaran S, Danafar H, Kheiri Manjili HJABS, et al. Glutathione (GSH) peptide conjugated magnetic nanoparticles as blood-brain barrier shuttle for MRI-monitored brain delivery of paclitaxel. ACS Biomater Sci Eng. 2019;5(4):1677.","journal-title":"ACS Biomater Sci Eng"},{"key":"3415_CR83","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2012.06.022","volume":"164","author":"PJ Gaillard","year":"2012","unstructured":"Gaillard PJ, Appeldoorn CC, Rip J, Dorland R, van der Pol SM, Kooij G, de Vries HE, Reijerkerk A. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J Control Release. 2012;164:364\u20139.","journal-title":"J Control Release"},{"key":"3415_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073742","author":"SB Al Rihani","year":"2021","unstructured":"Al Rihani SB, Darakjian LI, Deodhar M, Dow P, Turgeon J, Michaud V. Disease-induced modulation of drug transporters at the blood-brain barrier level. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22073742.","journal-title":"Int J Mol Sci"},{"key":"3415_CR85","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx. 2005;2:86\u201398.","journal-title":"NeuroRx"},{"key":"3415_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120463","volume":"298","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA, Saebfar H, Mahabady MK, Orouei S, Hushmandi K, Entezari M, Hashemi M, Aref AR, Hamblin MR, Ang HL, et al. Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy. Life Sci. 2022;298: 120463.","journal-title":"Life Sci"},{"key":"3415_CR87","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1021\/acs.molpharmaceut.5b00002","volume":"12","author":"R Nieto Montesinos","year":"2015","unstructured":"Nieto Montesinos R, B\u00e9duneau A, Lamprecht A, Pellequer Y. Liposomes coloaded with elacridar and tariquidar to modulate the p-glycoprotein at the blood-brain barrier. Mol Pharm. 2015;12:3829\u201338.","journal-title":"Mol Pharm"},{"key":"3415_CR88","doi-asserted-by":"publisher","first-page":"17349","DOI":"10.1074\/jbc.REV120.009132","volume":"295","author":"W Lee","year":"2020","unstructured":"Lee W, Ha JM, Sugiyama Y. Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides. J Biol Chem. 2020;295:17349\u201364.","journal-title":"J Biol Chem"},{"key":"3415_CR89","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1161\/STROKEAHA.123.043649","volume":"54","author":"EI Williams","year":"2023","unstructured":"Williams EI, Betterton RD, Stanton JA, Moreno-Rodriguez VM, Lochhead JJ, Davis TP, Ronaldson PT. Oatp (organic anion transporting polypeptide)-mediated transport: a mechanism for atorvastatin neuroprotection in stroke. Stroke. 2023;54:2875\u201385.","journal-title":"Stroke"},{"key":"3415_CR90","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1124\/molpharm.123.000703","volume":"104","author":"A Sun","year":"2023","unstructured":"Sun A, Hagenbuch B, Kelly EJ, Wang J. Molecular mechanisms of organic anion transporting polypeptide-mediated organic anion clearance at the blood-cerebrospinal fluid barrier. Mol Pharmacol. 2023;104:255\u201365.","journal-title":"Mol Pharmacol"},{"key":"3415_CR91","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/pr.119.018762","volume":"72","author":"MA Felmlee","year":"2020","unstructured":"Felmlee MA, Jones RS, Rodriguez-Cruz V, Follman KE, Morris ME. Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease. Pharmacol Rev. 2020;72:466\u201385.","journal-title":"Pharmacol Rev"},{"key":"3415_CR92","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s11095-016-1912-6","volume":"33","author":"NY Lee","year":"2016","unstructured":"Lee NY, Kang YS. In vivo and in vitro evidence for brain uptake of 4-phenylbutyrate by the monocarboxylate transporter 1 (MCT1). Pharm Res. 2016;33:1711\u201322.","journal-title":"Pharm Res"},{"key":"3415_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112581","volume":"252","author":"J Cong","year":"2020","unstructured":"Cong J, Ruan Y, Lyu Q, Qin X, Qi X, Liu W, Kang L, Zhang J, Wu C. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids. J Ethnopharmacol. 2020;252: 112581.","journal-title":"J Ethnopharmacol"},{"key":"3415_CR94","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1007\/s12035-024-04506-9","volume":"62","author":"HS Ahmed","year":"2025","unstructured":"Ahmed HS. The multifaceted role of L-type amino acid transporter 1 at the blood-brain barrier: structural implications and therapeutic potential. Mol Neurobiol. 2025;62:3813\u201332.","journal-title":"Mol Neurobiol"},{"key":"3415_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183298","volume":"1862","author":"Y Hashimoto","year":"2020","unstructured":"Hashimoto Y, Campbell M. Tight junction modulation at the blood-brain barrier: current and future perspectives. Biochim Biophys Acta Biomembr. 2020;1862: 183298.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"3415_CR96","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nyas.14787","volume":"1514","author":"E Wakayama","year":"2022","unstructured":"Wakayama E, Kuzu T, Tachibana K, Hirayama R, Okada Y, Kondoh M. Modifying the blood-brain barrier by targeting claudin-5: Safety and risks. Ann N Y Acad Sci. 2022;1514:62\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"3415_CR97","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCRESAHA.120.316742","volume":"127","author":"N Kakogiannos","year":"2020","unstructured":"Kakogiannos N, Ferrari L, Giampietro C, Scalise AA, Maderna C, Rav\u00e0 M, Taddei A, Lampugnani MG, Pisati F, Malinverno M, et al. JAM-A acts via C\/EBP-\u03b1 to promote claudin-5 expression and enhance endothelial barrier function. Circ Res. 2020;127:1056\u201373.","journal-title":"Circ Res"},{"key":"3415_CR98","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fphys.2020.00914","volume":"11","author":"JJ Lochhead","year":"2020","unstructured":"Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders. Front Physiol. 2020;11:914.","journal-title":"Front Physiol"},{"key":"3415_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202209239","author":"D Zhang","year":"2022","unstructured":"Zhang D, Sun Y, Wang S, Zou Y, Zheng M. Brain-targeting metastatic tumor cell membrane cloaked biomimetic nanomedicines mediate potent chemodynamic and rnai combinational therapy of glioblastoma. Adv Funct Materials. 2022. https:\/\/doi.org\/10.1002\/adfm.202209239.","journal-title":"Adv Funct Materials"},{"key":"3415_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202203958","volume":"34","author":"Y Zou","year":"2022","unstructured":"Zou Y, Wang Y, Xu S, Liu Y, Yin J, Lovejoy DB, Zheng M, Liang XJ, Park JB, Efremov YM, et al. Brain co-delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy. Adv Mater. 2022;34: e2203958.","journal-title":"Adv Mater"},{"key":"3415_CR101","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12987-020-00182-8","volume":"17","author":"KA Kim","year":"2020","unstructured":"Kim KA, Kim D, Kim JH, Shin YJ, Kim ES, Akram M, Kim EH, Majid A, Baek SH, Bae ON. Autophagy-mediated occludin degradation contributes to blood-brain barrier disruption during ischemia in bEnd.3 brain endothelial cells and rat ischemic stroke models. Fluids Barriers CNS. 2020;17:21.","journal-title":"Fluids Barriers CNS"},{"key":"3415_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156063","volume":"135","author":"YW Lu","year":"2024","unstructured":"Lu YW, Wang YJ, Wang Z, Ren S, Gong XJ, Hu JN, Zhang JT, Li W. Ginsenoside Rg2 alleviates astrocyte inflammation and ameliorates the permeability of the Alzheimer\u2019s disease related blood-brain barrier. Phytomedicine. 2024;135: 156063.","journal-title":"Phytomedicine"},{"key":"3415_CR103","volume":"16","author":"NS Aljehani","year":"2024","unstructured":"Aljehani NS, Al-Gunaid ST, Hobani AH, Alhinti MF, Khubrani YA, Abu-Hamoud LM, Alrayes AA, Alharbi LB, Sultan AA, Turkistani DA, et al. Ultrasound blood-brain barrier opening and aducanumab in alzheimer\u2019s disease: a systematic review and meta-analysis. Cureus. 2024;16: e68008.","journal-title":"Cureus"},{"key":"3415_CR104","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0022-3565(24)36406-7","volume":"280","author":"I Tamai","year":"1997","unstructured":"Tamai I, Sai Y, Kobayashi H, Kamata M, Wakamiya T, Tsuji A. Structure-internalization relationship for adsorptive-mediated endocytosis of basic peptides at the blood-brain barrier. J Pharmacol Exp Ther. 1997;280:410\u20135.","journal-title":"J Pharmacol Exp Ther"},{"key":"3415_CR105","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1038\/s41467-025-57598-9","volume":"16","author":"H Zheng","year":"2025","unstructured":"Zheng H, Zhang L, Bai X, Zhu J, Liu S, Ke Y, Lin Q, Yuan Y, Ji T. GCN5-targeted dual-modal probe across the blood-brain barrier for borders display in invasive glioblastoma. Nat Commun. 2025;16:2345.","journal-title":"Nat Commun"},{"key":"3415_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106510","volume":"185","author":"L Radtke","year":"2022","unstructured":"Radtke L, Majchrzak-Celi\u0144ska A, Awortwe C, Vater I, Nagel I, Sebens S, Cascorbi I, Kaehler M. CRISPR\/Cas9-induced knockout reveals the role of ABCB1 in the response to temozolomide, carmustine and lomustine in glioblastoma multiforme. Pharmacol Res. 2022;185: 106510.","journal-title":"Pharmacol Res"},{"key":"3415_CR107","doi-asserted-by":"publisher","first-page":"8926","DOI":"10.7150\/thno.62330","volume":"11","author":"M Xu","year":"2021","unstructured":"Xu M, Feng T, Liu B, Qiu F, Xu Y, Zhao Y, Zheng Y. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics. 2021;11:8926\u201344.","journal-title":"Theranostics"},{"key":"3415_CR108","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c10219","author":"J Cui","year":"2023","unstructured":"Cui J, Wang X, Li J, Zhu A, Du Y, Zeng W, Guo Y, Di L, Wang R. Immune exosomes loading self-assembled nanomicelles traverse the blood-brain barrier for chemo-immunotherapy against glioblastoma. ACS Nano. 2023. https:\/\/doi.org\/10.1021\/acsnano.2c10219.","journal-title":"ACS Nano"},{"key":"3415_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202402724","author":"Z Wang","year":"2024","unstructured":"Wang Z, Qing H, Li R, Li X, Guo X. M2 macrophage-derived exosomes inhibiting neutrophil extracellular traps for ischemic stroke therapy. Adv Funct Mater. 2024. https:\/\/doi.org\/10.1002\/adfm.202402724.","journal-title":"Adv Funct Mater"},{"issue":"21","key":"3415_CR110","doi-asserted-by":"publisher","first-page":"15635","DOI":"10.3390\/ijms242115635","volume":"24","author":"Z Osaid","year":"2023","unstructured":"Osaid Z, Haider M, Hamoudi R, Harati R. Exosomes interactions with the blood-brain barrier: implications for cerebral disorders and therapeutics. Int J Mol Sci. 2023;24(21):15635.","journal-title":"Int J Mol Sci"},{"key":"3415_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12255","volume":"11","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Zhai Y, Hao Y, Wang Q, Han F, Zheng W, Hong J, Cui L, Jin W, Ma S, et al. Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides. J Extracell Vesicles. 2022;11: e12255.","journal-title":"J Extracell Vesicles"},{"key":"3415_CR112","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","volume":"18","author":"S Jiang","year":"2024","unstructured":"Jiang S, Cai G, Yang Z, Shi H, Zeng H, Ye Q, Hu Z, Wang Z. Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of Alzheimer\u2019s disease. ACS Nano. 2024;18:11753\u201368.","journal-title":"ACS Nano"},{"key":"3415_CR113","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/17425247.2022.2108786","volume":"19","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Jin K, Zhang B, Peng S, Nayak AK, Pang Z. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics. Expert Opin Drug Deliv. 2022;19:965\u201384.","journal-title":"Expert Opin Drug Deliv"},{"key":"3415_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303278","volume":"13","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang W, Hou L, Geng W, Wang J, Kong Y, Liu C, Zeng X, Kong D. A Biomimetic upconversion nanobait-based near infrared light guided photodynamic therapy alleviates Alzheimer\u2019s disease by inhibiting \u03b2-amyloid aggregation. Adv Healthc Mater. 2024;13: e2303278.","journal-title":"Adv Healthc Mater"},{"key":"3415_CR115","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","volume":"20","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wan S, Yang S, Hu H, Zhang C, Lai J, Zhou J, Chen W, Tang X, Luo J, et al. Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment. J Nanobiotechnol. 2022;20:542.","journal-title":"J Nanobiotechnol"},{"key":"3415_CR116","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.7150\/thno.99260","volume":"14","author":"C Geng","year":"2024","unstructured":"Geng C, Ren X, Cao P, Chu X, Wei P, Liu Q, Lu Y, Fu B, Li W, Li Y, et al. Macrophage membrane-biomimetic nanoparticles target inflammatory microenvironment for epilepsy treatment. Theranostics. 2024;14:6652\u201370.","journal-title":"Theranostics"},{"key":"3415_CR117","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2021.03.027","volume":"509","author":"J Zhang","year":"2021","unstructured":"Zhang J, Chen H, Chen C, Liu H, He Y, Zhao J, Yang P, Mao Q, Xia H. Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24\/endostatin enhances glioma therapy. Cancer Lett. 2021;509:26\u201338.","journal-title":"Cancer Lett"},{"key":"3415_CR118","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1007\/s12035-023-03779-w","volume":"61","author":"SL Lin","year":"2024","unstructured":"Lin SL, Lee W, Liu SP, Chang YW, Jeng LB, Shyu WC. Novel programmed death ligand 1-AKT-engineered mesenchymal stem cells promote neuroplasticity to target stroke therapy. Mol Neurobiol. 2024;61:3819\u201335.","journal-title":"Mol Neurobiol"},{"key":"3415_CR119","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMoa2308719","volume":"390","author":"AR Rezai","year":"2024","unstructured":"Rezai AR, D\u2019Haese PF, Finomore V, Carpenter J, Ranjan M, Wilhelmsen K, Mehta RI, Wang P, Najib U, Teixeira VL, et al. Ultrasound blood-brain barrier opening and aducanumab in Alzheimer\u2019s disease. N Engl J Med. 2024;390:55\u201362.","journal-title":"N Engl J Med"},{"key":"3415_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302134","volume":"10","author":"B Li","year":"2023","unstructured":"Li B, Lin Y, Chen G, Cai M, Zhong H, Xiao Z, Lin M, Li T, Cai Y, Shuai X, et al. Anchoring microbubbles on cerebrovascular endothelium as a new strategy enabling low-energy ultrasound-assisted delivery of varisized agents across blood-brain barrier. Adv Sci (Weinh). 2023;10: e2302134.","journal-title":"Adv Sci (Weinh)"},{"key":"3415_CR121","doi-asserted-by":"publisher","first-page":"24139","DOI":"10.1021\/acsnano.4c05270","volume":"18","author":"G Kwak","year":"2024","unstructured":"Kwak G, Grewal A, Slika H, Mess G, Li H, Kwatra M, Poulopoulos A, Woodworth GF, Eberhart CG, Ko HS, et al. Brain nucleic acid delivery and genome editing via focused ultrasound-mediated blood-brain barrier opening and long-circulating nanoparticles. ACS Nano. 2024;18:24139\u201353.","journal-title":"ACS Nano"},{"issue":"6","key":"3415_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202413164","volume":"37","author":"Z Xu","year":"2024","unstructured":"Xu Z, Li X, Yang Z, Zhang Z, Zhang Y, Fan M, Zeng Y, Kang M, Shen Y, Wang D, et al. An NIR-II Two-photon excitable AIE photosensitizer for precise and efficient treatment of orthotopic small-size glioblastoma. Adv Mater. 2024;37(6): e2413164.","journal-title":"Adv Mater"},{"key":"3415_CR123","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.7150\/thno.70372","volume":"13","author":"F Padilla","year":"2023","unstructured":"Padilla F, Brenner J, Prada F, Klibanov AL. Theranostics in the vasculature: bioeffects of ultrasound and microbubbles to induce vascular shutdown. Theranostics. 2023;13:4079\u2013101.","journal-title":"Theranostics"},{"key":"3415_CR124","doi-asserted-by":"publisher","first-page":"8821","DOI":"10.7150\/thno.47983","volume":"10","author":"CT Curley","year":"2020","unstructured":"Curley CT, Stevens AD, Mathew AS, Stasiak K, Garrison WJ, Miller GW, Sheybani ND, Engelhard VH, Bullock TNJ, Price RJ. Immunomodulation of intracranial melanoma in response to blood-tumor barrier opening with focused ultrasound. Theranostics. 2020;10:8821\u201333.","journal-title":"Theranostics"},{"key":"3415_CR125","doi-asserted-by":"publisher","first-page":"1274642","DOI":"10.3389\/fneur.2023.1274642","volume":"14","author":"M Zhou","year":"2023","unstructured":"Zhou M, Fu X, Ma B, Chen Z, Cheng Y, Liu L, Kan S, Zhao X, Feng S, Jiang Z, et al. Effects of low-intensity ultrasound opening the blood-brain barrier on Alzheimer\u2019s disease-a mini review. Front Neurol. 2023;14:1274642.","journal-title":"Front Neurol"},{"key":"3415_CR126","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","volume":"24","author":"AM Sonabend","year":"2023","unstructured":"Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY, Gomez C, Bebawy JF, Liu BP, Bouchoux G, et al. Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. Lancet Oncol. 2023;24:509\u201322.","journal-title":"Lancet Oncol"},{"key":"3415_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105451","volume":"9","author":"B Li","year":"2022","unstructured":"Li B, Chen X, Qiu W, Zhao R, Duan J, Zhang S, Pan Z, Zhao S, Guo Q, Qi Y, et al. Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy. Adv Sci (Weinh). 2022;9: e2105451.","journal-title":"Adv Sci (Weinh)"},{"key":"3415_CR128","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4103\/1673-5374.385875","volume":"19","author":"S Gotoh","year":"2024","unstructured":"Gotoh S, Kawabori M, Fujimura M. Intranasal administration of stem cell-derived exosomes for central nervous system diseases. Neural Regen Res. 2024;19:1249\u201355.","journal-title":"Neural Regen Res"},{"key":"3415_CR129","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2023.06.001","volume":"359","author":"Y Lu","year":"2023","unstructured":"Lu Y, Wang JT, Li N, Zhu X, Li Y, Bansal S, Wang Y, Al-Jamal KT. Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability. J Control Release. 2023;359:257\u201367.","journal-title":"J Control Release"},{"key":"3415_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202405781","volume":"20","author":"Q Feng","year":"2024","unstructured":"Feng Q, Zhang X, Zhao X, Liu J, Wang Q, Yao Y, Xiao H, Zhu Y, Zhang W, Wang L. Intranasal delivery of pure nanodrug loaded liposomes for alzheimer\u2019s disease treatment by efficiently regulating microglial polarization. Small. 2024;20: e2405781.","journal-title":"Small"},{"key":"3415_CR131","first-page":"949","volume":"39","author":"LP Wang","year":"2014","unstructured":"Wang LP, Feng JF, Hu KL. Progress in regulation effect of aromatic refreshing traditional Chinese medicine on BBB permeability and its mechanism. Zhongguo Zhong Yao Za Zhi. 2014;39:949\u201354.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"3415_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.606682","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Ren M, Wang J, Ma R, Chen H, Xie Q, Li H, Li J, Wang J. Progress in borneol intervention for ischemic stroke: a systematic review. Front Pharmacol. 2021;12: 606682.","journal-title":"Front Pharmacol"},{"key":"3415_CR133","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2174\/1567201820666230119120314","volume":"21","author":"A Hui","year":"2024","unstructured":"Hui A, Zhang Z, Wang J, Yang L, Deng S, Zhang W, Zhou A, Wu Z. Enhanced brain targeting delivery of salvianic acid using borneol as a promoter of blood\/brain transport and regulator of P-gp. Curr Drug Deliv. 2024;21:726\u201333.","journal-title":"Curr Drug Deliv"},{"key":"3415_CR134","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1021\/acs.jcim.0c00892","volume":"61","author":"R Yang","year":"2021","unstructured":"Yang R, Chen Z, Xie F, Xie M, Liu N, Su Z, Gu J, Zhao R. (+\/-)-Borneol reverses mitoxantrone resistance against P-glycoprotein. J Chem Inf Model. 2021;61:252\u201362.","journal-title":"J Chem Inf Model"},{"key":"3415_CR135","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jep.2015.01.003","volume":"162","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Wu D, Wu J, Ou Y, Mu C, Han B, Zhang Q. Improved blood-brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling. J Ethnopharmacol. 2015;162:270\u20137.","journal-title":"J Ethnopharmacol"},{"key":"3415_CR136","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acschemneuro.3c00625","volume":"15","author":"FR Li","year":"2024","unstructured":"Li FR, Yu Y, Du YM, Kong L, Liu Y, Wang JH, Chen MH, Liu M, Zhang ZX, Li XT, et al. Borneol-modified schisandrin b micelles cross the blood-brain barrier to treat alzheimer\u2019s disease in aged mice. ACS Chem Neurosci. 2024;15:593\u2013607.","journal-title":"ACS Chem Neurosci"},{"key":"3415_CR137","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/03639045.2024.2302886","volume":"50","author":"Y Liu","year":"2024","unstructured":"Liu Y, Cai JY, Liu Y, Zhang L, Guo RB, Li XT, Ma LY, Kong L. Borneol-modified docetaxel plus tetrandrine micelles for treatment of drug-resistant brain glioma. Drug Dev Ind Pharm. 2024;50:135\u201349.","journal-title":"Drug Dev Ind Pharm"},{"key":"3415_CR138","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.21037\/tcr-23-1487","volume":"12","author":"X Tan","year":"2023","unstructured":"Tan X, Zhang K, Shi W, Tang Z. Research progress on the regulation and mechanism of borneol on the blood-brain barrier in pathological states: a narrative review focused on ischemic stroke and cerebral glioma. Transl Cancer Res. 2023;12:3198\u2013209.","journal-title":"Transl Cancer Res"},{"key":"3415_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41427-019-0138-6","author":"J Liang","year":"2019","unstructured":"Liang J, Zhu Y, Gao C, Ling C, Qin J, Wang Q, Huang Y, Lu W. Menthol-modified BSA nanoparticles for glioma targeting therapy using an energy restriction strategy. NPG Asia Materials. 2019. https:\/\/doi.org\/10.1038\/s41427-019-0138-6.","journal-title":"NPG Asia Materials"},{"key":"3415_CR140","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1248\/cpb.c17-00267","volume":"65","author":"L Li","year":"2017","unstructured":"Li L, Wang N, Jin Q, Wu Q, Liu Y, Wang Y. Protection of Tong-Qiao-Huo-Xue decoction against cerebral ischemic injury through reduction blood-brain barrier permeability. Chem Pharm Bull (Tokyo). 2017;65:1004\u201310.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"3415_CR141","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijpharm.2013.08.017","volume":"456","author":"ZZ Chen","year":"2013","unstructured":"Chen ZZ, Lu Y, Du SY, Shang KX, Cai CB. Influence of borneol and muscone on geniposide transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model. Int J Pharm. 2013;456:73\u20139.","journal-title":"Int J Pharm"},{"key":"3415_CR142","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.7150\/thno.41322","volume":"10","author":"S Kang","year":"2020","unstructured":"Kang S, Duan W, Zhang S, Chen D, Feng J, Qi N. Muscone\/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma. Theranostics. 2020;10:4308\u201322.","journal-title":"Theranostics"},{"key":"3415_CR143","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.biopha.2017.03.083","volume":"90","author":"N Wang","year":"2017","unstructured":"Wang N, Zhang Q, Ning B, Luo L, Fang Y. \u03b2-Asarone promotes Temozolomide\u2019s entry into glioma cells and decreases the expression of P-glycoprotein and MDR1. Biomed Pharmacother. 2017;90:368\u201374.","journal-title":"Biomed Pharmacother"},{"key":"3415_CR144","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1080\/10717544.2018.1516005","volume":"25","author":"JY Wu","year":"2018","unstructured":"Wu JY, Li YJ, Yang L, Hu YY, Hu XB, Tang TT, Wang JM, Liu XY, Xiang DX. Borneol and \u0391-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors. Drug Deliv. 2018;25:1858\u201364.","journal-title":"Drug Deliv"},{"key":"3415_CR145","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/1440-1681.12570","volume":"43","author":"L Huang","year":"2016","unstructured":"Huang L, Deng M, He Y, Lu S, Ma R, Fang Y. \u03b2-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain. Clin Exp Pharmacol Physiol. 2016;43:634\u201343.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3415_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123351","volume":"644","author":"X Zhao","year":"2023","unstructured":"Zhao X, Sun L, Wang J, Xu X, Ni S, Liu M, Hu K. Nose to brain delivery of Astragaloside IV by \u03b2-Asarone modified chitosan nanoparticles for multiple sclerosis therapy. Int J Pharm. 2023;644: 123351.","journal-title":"Int J Pharm"},{"key":"3415_CR147","doi-asserted-by":"publisher","first-page":"115646","DOI":"10.1016\/j.jep.2022.115646","volume":"298","author":"SY Shuai","year":"2022","unstructured":"Shuai SY, Liu SS, Liu XJ, Zhang GS, Zheng Q, Yue PF, Yang M, Hu PY. Essential oil of Ligusticum chuanxiong Hort regulated P-gp protein and tight junction protein to change pharmacokinetic parameters of temozolomide in blood, brain and tumor. J Ethnopharmacol. 2022;298:115646.","journal-title":"J Ethnopharmacol"},{"key":"3415_CR148","doi-asserted-by":"publisher","first-page":"11676","DOI":"10.1021\/acs.jafc.1c02898","volume":"69","author":"R Shimazu","year":"2021","unstructured":"Shimazu R, Anada M, Miyaguchi A, Nomi Y, Matsumoto H. Evaluation of blood-brain barrier permeability of polyphenols, anthocyanins, and their metabolites. J Agric Food Chem. 2021;69:11676\u201386.","journal-title":"J Agric Food Chem"},{"key":"3415_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26164897","author":"K Unno","year":"2021","unstructured":"Unno K, Nakamura Y. Green tea suppresses brain aging. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26164897.","journal-title":"Molecules"},{"key":"3415_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115447","volume":"264","author":"J Huang","year":"2023","unstructured":"Huang J, Sun X, Wang Y, Su J, Li G, Wang X, Yang Y, Zhang Y, Li B, Zhang G, et al. Biological interactions of polystyrene nanoplastics: their cytotoxic and immunotoxic effects on the hepatic and enteric systems. Ecotoxicol Environ Saf. 2023;264: 115447.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3415_CR151","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejpb.2021.02.010","volume":"161","author":"S Patnaik","year":"2021","unstructured":"Patnaik S, Gorain B, Padhi S, Choudhury H, Gabr GA, Md S, Kumar Mishra D, Kesharwani P. Recent update of toxicity aspects of nanoparticulate systems for drug delivery. Eur J Pharm Biopharm. 2021;161:100\u201319.","journal-title":"Eur J Pharm Biopharm"},{"key":"3415_CR152","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","volume":"389","author":"RJ Bateman","year":"2023","unstructured":"Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, et al. Two phase 3 trials of gantenerumab in early Alzheimer\u2019s disease. N Engl J Med. 2023;389:1862\u201376.","journal-title":"N Engl J Med"},{"key":"3415_CR153","first-page":"186","volume":"6","author":"C Dmello","year":"2024","unstructured":"Dmello C, Brenner A, Piccioni D, Wen PY, Drappatz J, Mrugala M, Lewis LD, Schiff D, Fadul CE, Chamberlain M, et al. Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma. Neurooncol Adv. 2024;6:186.","journal-title":"Neurooncol Adv"},{"key":"3415_CR154","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.7150\/thno.94206","volume":"14","author":"S Bae","year":"2024","unstructured":"Bae S, Liu K, Pouliopoulos AN, Ji R, Jim\u00e9nez-Gamb\u00edn S, Yousefian O, Kline-Schoder AR, Batts AJ, Tsitsos FN, Kokossis D, et al. Transcranial blood-brain barrier opening in Alzheimer\u2019s disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping. Theranostics. 2024;14:4519\u201335.","journal-title":"Theranostics"},{"key":"3415_CR155","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12987-023-00447-y","volume":"20","author":"RI Mehta","year":"2023","unstructured":"Mehta RI, Carpenter JS, Mehta RI, Haut MW, Wang P, Ranjan M, Najib U, D\u2019Haese PF, Rezai AR. Ultrasound-mediated blood-brain barrier opening uncovers an intracerebral perivenous fluid network in persons with Alzheimer\u2019s disease. Fluids Barriers CNS. 2023;20:46.","journal-title":"Fluids Barriers CNS"},{"key":"3415_CR156","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1021\/ci900384c","volume":"50","author":"Y Fan","year":"2010","unstructured":"Fan Y, Unwalla R, Denny RA, Di L, Kerns EH, Diller DJ, Humblet C. Insights for predicting blood-brain barrier penetration of CNS targeted molecules using QSPR approaches. J Chem Inf Model. 2010;50:1123\u201333.","journal-title":"J Chem Inf Model"},{"key":"3415_CR157","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1021\/ci050303i","volume":"46","author":"P Garg","year":"2006","unstructured":"Garg P, Verma J. In silico prediction of blood brain barrier permeability: an artificial neural network model. J Chem Inf Model. 2006;46:289\u201397.","journal-title":"J Chem Inf Model"},{"key":"3415_CR158","first-page":"10068","volume":"6","author":"Z Wu","year":"2024","unstructured":"Wu Z, Zhang O, Wang X, Fu L, Zhao H, Wang J, Du H, Jiang D, Deng Y, Cao D. Leveraging language model for advanced multiproperty molecular optimization via prompt engineering. Nature Machine Intell. 2024;6:10068.","journal-title":"Nature Machine Intell"},{"key":"3415_CR159","doi-asserted-by":"crossref","unstructured":"Xu S, Xie L. Dumpling GNN: Hybrid GNN Enables Better ADC Payload Activity Prediction Based on Chemical Structure. 2024.","DOI":"10.3390\/ijms26104859"},{"key":"3415_CR160","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1021\/acs.jcim.4c01792","volume":"65","author":"N Tao","year":"2025","unstructured":"Tao N, Abe M. Bayesian flow network framework for chemistry tasks. J Chem Inf Model. 2025;65:1178\u201387.","journal-title":"J Chem Inf Model"},{"key":"3415_CR161","first-page":"0004","volume":"2022","author":"XC Zhang","year":"2022","unstructured":"Zhang XC, Wu CK, Yi JC, Zeng XX, Yang CQ, Lu AP, Hou TJ, Cao DS. Pushing the boundaries of molecular property prediction for drug discovery with multitask learning BERT enhanced by SMILES enumeration. Research (Wash D C). 2022;2022:0004.","journal-title":"Research (Wash D C)"},{"key":"3415_CR162","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13321-022-00619-2","volume":"14","author":"X Tong","year":"2022","unstructured":"Tong X, Wang D, Ding X, Tan X, Ren Q, Chen G, Rong Y, Xu T, Huang J, Jiang H, et al. Blood-brain barrier penetration prediction enhanced by uncertainty estimation. J Cheminform. 2022;14:44.","journal-title":"J Cheminform"},{"key":"3415_CR163","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-023-01339-1","volume":"8","author":"Q Lv","year":"2023","unstructured":"Lv Q, Chen G, He H, Yang Z, Zhao L, Zhang K, Chen CY. TCMBank-the largest TCM database provides deep learning-based Chinese-Western medicine exclusion prediction. Signal Transduct Target Ther. 2023;8:127.","journal-title":"Signal Transduct Target Ther"},{"key":"3415_CR164","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jconrel.2022.12.029","volume":"353","author":"LE McCoubrey","year":"2023","unstructured":"McCoubrey LE, Favaron A, Awad A, Orlu M, Gaisford S, Basit AW. Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics. J Control Release. 2023;353:1107\u201326.","journal-title":"J Control Release"},{"key":"3415_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071916","author":"LK Vora","year":"2023","unstructured":"Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15071916.","journal-title":"Pharmaceutics"},{"key":"3415_CR166","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad419","author":"J Dong","year":"2023","unstructured":"Dong J, Wu Z, Xu H, Ouyang D. FormulationAI: a novel web-based platform for drug formulation design driven by artificial intelligence. Brief Bioinform. 2023. https:\/\/doi.org\/10.1093\/bib\/bbad419.","journal-title":"Brief Bioinform"},{"key":"3415_CR167","doi-asserted-by":"publisher","first-page":"20049","DOI":"10.1149\/10701.20049ecst","volume":"107","author":"K Navyaja","year":"2022","unstructured":"Navyaja K, Kamaraj R, Bharathi M. The trending role of artificial intelligence and its applications in formulation of solid dosage forms: a review. ECS Trans. 2022;107:20049.","journal-title":"ECS Trans"},{"key":"3415_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.016","volume":"175","author":"P Bannigan","year":"2021","unstructured":"Bannigan P, Aldeghi M, Bao Z, H\u00e4se F, Aspuru-Guzik A, Allen C. Machine learning directed drug formulation development. Adv Drug Deliv Rev. 2021;175: 113806.","journal-title":"Adv Drug Deliv Rev"},{"key":"3415_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102112","volume":"23","author":"S Lakkadwala","year":"2020","unstructured":"Lakkadwala S, Dos Santos Rodrigues B, Sun C, Singh J. Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo. Nanomedicine. 2020;23: 102112.","journal-title":"Nanomedicine"},{"key":"3415_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.146738","volume":"1734","author":"B Dos Santos Rodrigues","year":"2020","unstructured":"Dos Santos Rodrigues B, Arora S, Kanekiyo T, Singh J. Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes. Brain Res. 2020;1734: 146738.","journal-title":"Brain Res"},{"key":"3415_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102225","volume":"28","author":"B Dos Santos Rodrigues","year":"2020","unstructured":"Dos Santos Rodrigues B, Kanekiyo T, Singh J. In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA. Nanomedicine. 2020;28: 102225.","journal-title":"Nanomedicine"},{"key":"3415_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106319","volume":"180","author":"Y Cao","year":"2023","unstructured":"Cao Y, Jin L, Zhang S, Lv Z, Yin N, Zhang H, Zhang T, Wang Y, Chen Y, Liu X, et al. Blood-brain barrier permeable and multi-stimuli responsive nanoplatform for orthotopic glioma inhibition by synergistic enhanced chemo-\/chemodynamic\/photothermal\/starvation therapy. Eur J Pharm Sci. 2023;180: 106319.","journal-title":"Eur J Pharm Sci"},{"key":"3415_CR173","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12951-021-01220-9","volume":"20","author":"HS Kim","year":"2022","unstructured":"Kim HS, Seo M, Park TE, Lee DY. A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy. J Nanobiotechnology. 2022;20:14.","journal-title":"J Nanobiotechnology"},{"key":"3415_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.112615","volume":"133","author":"YC Kuo","year":"2022","unstructured":"Kuo YC, Lee YJ, Rajesh R. Enhanced activity of AZD5582 and SM-164 in rabies virus glycoprotein-lactoferrin-liposomes to downregulate inhibitors of apoptosis proteins in glioblastoma. Biomater Adv. 2022;133: 112615.","journal-title":"Biomater Adv"},{"key":"3415_CR175","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100316","volume":"10","author":"L Li","year":"2021","unstructured":"Li L, Lu Y, Xu X, Yang X, Chen L, Jiang C, Wang Y, Hu W, Wei X, Yang Z. Catalytic-enhanced lactoferrin-functionalized Au-Bi(2) Se(3) nanodots for Parkinson\u2019s disease therapy via reactive oxygen attenuation and mitochondrial protection. Adv Healthc Mater. 2021;10: e2100316.","journal-title":"Adv Healthc Mater"},{"key":"3415_CR176","doi-asserted-by":"publisher","first-page":"30523","DOI":"10.1021\/acsami.2c05354","volume":"14","author":"Z Lv","year":"2022","unstructured":"Lv Z, Jin L, Gao W, Cao Y, Zhang H, Xue D, Yin N, Zhang T, Wang Y, Zhang H. Novel YOF-Based theranostic agents with a cascade effect for NIR-II fluorescence imaging and synergistic starvation\/photodynamic therapy of orthotopic gliomas. ACS Appl Mater Interfaces. 2022;14:30523\u201332.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3415_CR177","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s13346-023-01432-6","volume":"14","author":"N Ouyang","year":"2024","unstructured":"Ouyang N, Yang C, Li X, Zheng Z, Xu Y, Wang Y, Xiong W, Wu H. Development of lactoferrin-coated multifunctional copolymer micelles to cross the blood-brain barrier. Drug Deliv Transl Res. 2024;14:773\u201387.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3415_CR178","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/pharmaceutics14010185","volume":"14","author":"MI Teixeira","year":"2022","unstructured":"Teixeira MI, Lopes CM, Gon\u00e7alves H, Catita J, Silva AM, Rodrigues F, Amaral MH, Costa PC. Formulation, characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain. Pharmaceutics. 2022;14(1):185.","journal-title":"Pharmaceutics"},{"key":"3415_CR179","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1021\/acs.molpharmaceut.3c00239","volume":"20","author":"J Zhang","year":"2023","unstructured":"Zhang J, Fang R, Li Y, Jin J, Yang F, Chen J. Encapsulation of Au(III) complex using lactoferrin nanoparticles to combat glioma. Mol Pharm. 2023;20:3632\u201344.","journal-title":"Mol Pharm"},{"issue":"5","key":"3415_CR180","doi-asserted-by":"publisher","first-page":"055041","DOI":"10.1088\/1748-605X\/ad6e47","volume":"19","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zhu X, Yang H, Tan J, Gong R, Mei C, Cai X, Su Z, Kong F. Lactoferrin\/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells. Biomed Mater. 2024;19(5):055041.","journal-title":"Biomed Mater"},{"key":"3415_CR181","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202303073","volume":"19","author":"J Liang","year":"2023","unstructured":"Liang J, Li L, Tian H, Wang Z, Liu G, Duan X, Guo M, Liu J, Zhang W, Nice EC, et al. Drug repurposing-based brain-targeting self-assembly nanoplatform using enhanced ferroptosis against glioblastoma. Small. 2023;19: e2303073.","journal-title":"Small"},{"key":"3415_CR182","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.596976","volume":"15","author":"CSB Singh","year":"2021","unstructured":"Singh CSB, Eyford BA, Abraham T, Munro L, Choi KB, Okon M, Vitalis TZ, Gabathuler R, Lu CJ, Pfeifer CG, et al. Discovery of a highly conserved peptide in the iron transporter melanotransferrin that traverses an intact blood brain barrier and localizes in neural cells. Front Neurosci. 2021;15: 596976.","journal-title":"Front Neurosci"},{"key":"3415_CR183","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","volume":"80","author":"Y Liu","year":"2016","unstructured":"Liu Y, An S, Li J, Kuang Y, He X, Guo Y, Ma H, Zhang Y, Ji B, Jiang C. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer\u2019s disease mice. Biomaterials. 2016;80:33\u201345.","journal-title":"Biomaterials"},{"key":"3415_CR184","doi-asserted-by":"publisher","first-page":"2209239","DOI":"10.1002\/adfm.202209239","volume":"32","author":"D Zhang","year":"2022","unstructured":"Zhang D, Sun Y, Wang S, Zou Y, Zheng M, Shi B. Brain-targeting metastatic tumor cell membrane cloaked biomimetic nanomedicines mediate potent chemodynamic and RNAi combinational therapy of glioblastoma. Adv Funct Mater. 2022;32:2209239.","journal-title":"Adv Funct Mater"},{"key":"3415_CR185","doi-asserted-by":"publisher","first-page":"2402724","DOI":"10.1002\/adfm.202402724","volume":"34","author":"Z Wang","year":"2024","unstructured":"Wang Z, Qing H, Li R, Li X, Guo X, Zhou S. M2 macrophage-derived exosomes inhibiting neutrophil extracellular traps for ischemic stroke therapy. Adv Funct Mater. 2024;34:2402724.","journal-title":"Adv Funct Mater"},{"key":"3415_CR186","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1021\/nn202399w","volume":"5","author":"L Li","year":"2011","unstructured":"Li L, Guan Y, Liu H, Hao N, Liu T, Meng X, Fu C, Li Y, Qu Q, Zhang Y, et al. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano. 2011;5:7462\u201370.","journal-title":"ACS Nano"},{"key":"3415_CR187","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.biomaterials.2019.04.026","volume":"211","author":"J Lai","year":"2019","unstructured":"Lai J, Deng G, Sun Z, Peng X, Li J, Gong P, Zhang P, Cai L. Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing Blood-Brain Barrier. Biomaterials. 2019;211:48\u201356.","journal-title":"Biomaterials"},{"key":"3415_CR188","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","volume":"348","author":"K Ogawa","year":"2022","unstructured":"Ogawa K, Kato N, Yoshida M, Hiu T, Matsuo T, Mizukami S, Omata D, Suzuki R, Maruyama K, Mukai H, et al. Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain. J Control Release. 2022;348:34\u201341.","journal-title":"J Control Release"},{"key":"3415_CR189","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12951-023-02074-z","volume":"21","author":"C He","year":"2023","unstructured":"He C, Wu Z, Zhuang M, Li X, Xue S, Xu S, Xu J, Wu Z, Lu M. Focused ultrasound-mediated blood-brain barrier opening combined with magnetic targeting cytomembrane based biomimetic microbubbles for glioblastoma therapy. J Nanobiotechnology. 2023;21:297.","journal-title":"J Nanobiotechnology"},{"key":"3415_CR190","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ijrobp.2020.12.019","volume":"110","author":"HJ Wei","year":"2021","unstructured":"Wei HJ, Upadhyayula PS, Pouliopoulos AN, Englander ZK, Zhang X, Jan CI, Guo J, Mela A, Zhang Z, Wang TJC, et al. Focused ultrasound-mediated blood-brain barrier opening increases delivery and efficacy of etoposide for glioblastoma treatment. Int J Radiat Oncol Biol Phys. 2021;110:539\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3415_CR191","first-page":"111","volume":"5","author":"P Martinez","year":"2023","unstructured":"Martinez P, Nault G, Steiner J, Wempe MF, Pierce A, Brunt B, Slade M, Song JJ, Mongin A, Song KH, et al. MRI-guided focused ultrasound blood-brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model. Neurooncol Adv. 2023;5:111.","journal-title":"Neurooncol Adv"},{"key":"3415_CR192","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202307081","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu Y, Tan Y, Cheng G, Ni Y, Xie A, Zhu X, Yin C, Zhang Y, Chen T. Customized intranasal hydrogel delivering methylene blue ameliorates cognitive dysfunction against Alzheimer\u2019s disease. Adv Mater. 2024;36: e2307081.","journal-title":"Adv Mater"},{"key":"3415_CR193","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202203182","volume":"18","author":"X Yang","year":"2022","unstructured":"Yang X, Yang W, Xia X, Lei T, Yang Z, Jia W, Zhou Y, Cheng G, Gao H. Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for alzheimer\u2019s disease therapy. Small. 2022;18: e2203182.","journal-title":"Small"},{"key":"3415_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202400304","volume":"8","author":"Z Duan","year":"2024","unstructured":"Duan Z, Zhou W, He S, Wang W, Huang H, Yi L, Zhang R, Chen J, Zan X, You C, et al. Intranasal delivery of curcumin nanoparticles improves neuroinflammation and neurological deficits in mice with intracerebral hemorrhage. Small Methods. 2024;8: e2400304.","journal-title":"Small Methods"},{"key":"3415_CR195","doi-asserted-by":"publisher","DOI":"10.3390\/gels9020130","author":"AB Nair","year":"2023","unstructured":"Nair AB, Chaudhary S, Jacob S, Patel D, Shinu P, Shah H, Chaudhary A, Aldhubiab B, Almuqbil RM, Alnaim AS, et al. Intranasal administration of dolutegravir-loaded nanoemulsion-based in situ gel for enhanced bioavailability and direct brain targeting. Gels. 2023. https:\/\/doi.org\/10.3390\/gels9020130.","journal-title":"Gels"},{"issue":"2","key":"3415_CR196","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/pharmaceutics17020191","volume":"17","author":"G Ke","year":"2025","unstructured":"Ke G, Zhang M, Hu P, Zhang J, Naeem A, Wang L, Xu H, Liu Y, Cao M, Zheng Q. Exploratory study on nanoparticle Co-Delivery of Temozolomide and Ligustilide for enhanced brain tumor therapy. Pharmaceutics. 2025;17(2):191.","journal-title":"Pharmaceutics"},{"key":"3415_CR197","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/ptr.5985","volume":"32","author":"Q Zheng","year":"2018","unstructured":"Zheng Q, Tang Y, Hu PY, Liu D, Zhang D, Yue P, Guo Y, Yang M. The influence and mechanism of ligustilide, senkyunolide I, and senkyunolide A on echinacoside transport through MDCK-MDR1 cells as blood-brain barrier in vitro model. Phytother Res. 2018;32:426\u201335.","journal-title":"Phytother Res"},{"key":"3415_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115683","volume":"168","author":"M Wang","year":"2023","unstructured":"Wang M, Hayashi H, Horinokita I, Asada M, Iwatani Y, Ren JG, Liu JX, Takagi N. Role of senkyunolide I in the promotion of neural stem\/progenitor cell proliferation via the Akt\/\u03b2-catenin pathway. Biomed Pharmacother. 2023;168: 115683.","journal-title":"Biomed Pharmacother"},{"key":"3415_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156229","volume":"135","author":"C Zhu","year":"2024","unstructured":"Zhu C, Wang S, Ma S, Zhang S, Wang Y, Li B, Zhang W, Sun Z. Gastrodin reduces A\u03b2 brain levels in an Alzheimer\u2019s disease mouse model by inhibiting P-glycoprotein ubiquitination. Phytomedicine. 2024;135: 156229.","journal-title":"Phytomedicine"},{"key":"3415_CR200","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","volume":"13","author":"C Xing","year":"2023","unstructured":"Xing C, Huang X, Wang D, Yu D, Hou S, Cui H, Song L. Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. Cell Biosci. 2023;13:106.","journal-title":"Cell Biosci"},{"key":"3415_CR201","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-023-01666-3","volume":"8","author":"J Qu","year":"2023","unstructured":"Qu J, Qiu B, Zhang Y, Hu Y, Wang Z, Guan Z, Qin Y, Sui T, Wu F, Li B, et al. The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling. Signal Transduct Target Ther. 2023;8:424.","journal-title":"Signal Transduct Target Ther"},{"key":"3415_CR202","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2174\/1871520620666200929151139","volume":"21","author":"M Ashrafizadeh","year":"2021","unstructured":"Ashrafizadeh M, Mohammadinejad R, Farkhondeh T, Samarghandian S. Protective effect of resveratrol against glioblastoma: a review. Anticancer Agents Med Chem. 2021;21:1216\u201327.","journal-title":"Anticancer Agents Med Chem"},{"key":"3415_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154933","volume":"118","author":"W Wang","year":"2023","unstructured":"Wang W, Yuan X, Mu J, Zou Y, Xu L, Chen J, Zhu X, Li B, Zeng Z, Wu X, et al. Quercetin induces MGMT(+) glioblastoma cells apoptosis via dual inhibition of Wnt3a\/\u03b2-Catenin and Akt\/NF-\u03baB signaling pathways. Phytomedicine. 2023;118: 154933.","journal-title":"Phytomedicine"},{"key":"3415_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153316","volume":"79","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zhu Q, Chen JY, OuYang D, Lu JH. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer\u2019s disease animal model: a systematic review. Phytomedicine. 2020;79: 153316.","journal-title":"Phytomedicine"},{"key":"3415_CR205","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41416-022-01800-y","volume":"127","author":"S Zhan","year":"2022","unstructured":"Zhan S, Lu L, Pan SS, Wei XQ, Miao RR, Liu XH, Xue M, Lin XK, Xu HL. Targeting NQO1\/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth. Br J Cancer. 2022;127:364\u201376.","journal-title":"Br J Cancer"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03415-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03415-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03415-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T14:02:46Z","timestamp":1748268166000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03415-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":205,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3415"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03415-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the journal policies and submit this manuscript in accordance with those policies. All authors agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}